Antimicrobial Susceptibility of beta-emolytic Streptococci Isolated during the Period of 1999 / 대한임상병리학회지
Korean Journal of Clinical Pathology
;
: 475-479, 2000.
Article
Dans Coréen
| WPRIM
| ID: wpr-135695
ABSTRACT
BACKGROUND:
Erythromycin is currently recommended as an alternative antibiotic for treatment of streptococcal infections in patients allergic to penicillins. Less than 5% of the group A streptococci are known as resistant to erythromycin but the resistance pattern differs among time and region. The purpose of this study was to determine the antimicrobial susceptibility of beta-emolytic streptococcal strains isolated during 1999 in Wonju.METHODS:
A total of 107 beta-emolytic streptococci were isolates from the Wonju Christian Hospital during 1999. The susceptibility to penicillin, erythromycin, tetracycline, vancomycin, ceftriaxone, chloramphenicol, and clindamycin was tested with agar dilution method.RESULTS:
No beta-emolytic streptococci strain was resistant to penicillin, ceftriaxone and vancomycin. Among beta-emolytic streptococci strains, 20-1%, 18-0% and 14-7% were resistant to tetracycline, erythromycin and clindamycin, respectively.CONCLUSIONS:
It appears prudent that active surveillance of the beta-emolytic streptococci for antibiotic resistance be implemented since there are no currently effective vaccines or other methods for controlling the spread of infections due to these virulent organisms.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pénicillines
/
Infections à streptocoques
/
Tétracycline
/
Ceftriaxone
/
Résistance microbienne aux médicaments
/
Vaccins
/
Clindamycine
/
Vancomycine
/
Chloramphénicol
/
Érythromycine
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
Korean Journal of Clinical Pathology
Année:
2000
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS